CoreAge Rx vs Livea
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Livea head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Livea a bad call — it's best for readers seeking nutrition and medical follow-up through a regional clinic network who can confirm location access and separate medication charges. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Livea |
|---|---|---|
| Brief Score | 94/100 (A) | 66/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Program and medication quote needed Medical page: $69/month program access, with medication extra. Separate GLP-1 page: semaglutide from $99/month. FAQ uses different medication-price wording; obtain the full selected bill and location eligibility. Full price detailsSemaglutide complete quote unknown; medical page says $69/month is program access with medication extra, while separate GLP-1 page advertises compounded semaglutide from $99/month |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Program and medication quote needed Medical page: program access from $69/month, with medication extra. No complete tirzepatide quote established. Compounded and branded options require clinical eligibility; confirm the full bill and physical-location access. Full price detailsTirzepatide complete quote unknown; program access advertised from $69/month with medication extra; compounded and branded options require a selected eligibility and cost quote |
| Coverage | US only; restrictions by state, confirmed at intake | FAQ lists Minnesota, Wisconsin, Iowa and Florida; telehealth terms focus on Minnesota/Wisconsin or separately confirmed eligibility. Confirm physical-location access. |
| Brand-name access | Not confirmed | FAQ specifically advertises branded Wegovy and Zepbound; selected availability, medication cost and insurance coverage require confirmation. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Livea: The medical page defines $69/month as program access and supervision, with medication extra. A separate page advertises semaglutide from $99; obtain the complete selected bill.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.